Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 27, 1999

View Archived Issues

Sepracor's progress in third quarter

Italian laboratory designs new phototherapeutic/photodiagnostic compounds

Antisense oligonucleotides that modulate human HER-2 expression patented

Rhone-Poulenc and Hoechst present new Aventis logo

Second-generation virus from Calydon begins clinical testing in prostate cancer

Coactinon effective and safe as part of first-line protease inhibitor-sparing regimen

Tenofovir disoproxil fumarate: clinical activity correlated with intracellular levels

PDE4-inhbitory pyridines disclosed by Janssen

Warner-Lambert patents new anticoagulants with quinolinone structure

Improved muscarinic agents for cognitive disorders

HMR's newest antiresorptive compounds

Schering-Plough files for marketing clearance for desloratadine on two continents

Protein Design Labs and Roche expand Zenapax partnership

StessGen begins trial of HspE7 for anal dysplasia

Alza and Crescendo report efficacy data for once-daily ADD/ADHD therapy

Pivotal data presented for Celgene's ADD/ADHD therapy

Cubist receives further grant funding for antiinfective research

Antihypertensive agent unexpectedly found to hold potential as male contraceptive

News from ASRM/CFAS '99: Hughes Institute hones in on anti-HIV spermicides

Dramatic results described for STI-571 in CML patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...